Clin2
NCT05972317Possibly a fitRecruiting

Study gut bacteria in IBS patients with and without treatment

Irritable Bowel Syndrome

Part of Digestive system clinical trials.

This study looks at stool (poop) samples to understand differences in gut bacteria in people with irritable bowel syndrome (IBS), depending on whether they’ve had treatment. It may help researchers find better ways to explain IBS and improve care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Be between 18 and 70 years old
  • Have irritable bowel syndrome (IBS)
  • Do not take antibiotics in the last 2 months
  • Do not take probiotic supplements in the last 1 month
  • Avoid pregnancy/breastfeeding in the last 3 months (and avoid fertility treatment)
  • Do not have IBD, diabetes type 1 or type 2, or a recent cancer/chemo history

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07467278Not yet recruiting
Low-FODMAP diet and gut health in irritable bowel syndrome

This trial tests whether a low-FODMAP diet can improve gut barrier function in people with irritable bowel syndrome. If you have IBS and are willing to follow a specific diet for a few weeks, this study may help you manage your symptoms.

NCT07212569Not yet recruiting
Gut bacteria differences in IBS versus healthy people

This study compares the types of bacteria and other tiny organisms in the small intestine of people with irritable bowel syndrome (IBS) and those without. By understanding these differences, doctors hope to find better ways to diagnose or treat IBS.

Xiamen, Fujian
NCT07494968Recruiting
Finding ways to track diet compliance in IBS patients

This study looks for signs in your body—like breath and blood tests—that can show how well you are following a special diet for IBS. It aims to find better ways to track diet compliance, which could help make dietary treatments more effective.

Ann Arbor, Michigan
NCT05361785Recruiting
Fecal transplant to help IBS food sensitivity

This study tests whether transferring gut bacteria from a healthy donor to a participant can reduce irritable bowel syndrome (IBS) symptoms related to food sensitivity. You may be asked to follow a low-FODMAP diet and receive a fecal microbiota transplant if you meet the study’s safety and health requirements.

Helsinki, Helsinki and Uusimaa
NCT05740319Recruiting
Test stool transplant to treat irritable bowel syndrome

This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.

Shanghai, Shanghai Municipality
NCT05120752Recruiting· Phase 3
Low FODMAP diet trial for IBS without lactose intolerance

This trial tests whether eating a low-FODMAP diet can reduce IBS symptoms in people who do not have lactose intolerance. It aims to improve moderate-to-severe IBS symptoms by changing what kinds of carbohydrates you eat.

Jette, Brussels Capital

Hear when a new Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.